EyeCool Therapeutics Announces Encouraging Interim Clinical Results for ETX-4143 in Chronic ...

BOSTON, MA, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- EyeCool Therapeutics, a clinical-stage ophthalmic ...